Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Domchek

Showing results (191-200 of 361) with videos related to

Pageof 37
Sort By:
Clinical Breast Cancer|February 14, 2008
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriersTara M Friebel, Susan M Domchek, Susan L Neuhausen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional AssayChunling Hu, Lisa R Susswein, Maegan E Roberts, et al.
Cell Reports|January 22, 2026
Immune gene diversity and STING1 variants in shaping cancer immunity across different genetic ancestry populationsXiaowen Hu, Jie Huang, Jiao Yuan, et al.
Cancer Research Communications|June 1, 2026
Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase 2a PLANETTE StudyRahul R Aggarwal, Antoine Italiano, Susan M Domchek, et al.
American Journal of Human Genetics|May 7, 2016
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast CancerKara N Maxwell, Steven N Hart, Joseph Vijai, et al.
Cancer|May 2, 2019
Detailed phenotyping reveals distinct trajectories of cardiovascular function and symptoms with exposure to modern breast cancer therapyBiniyam G Demissei, Brian S Finkelman, Rebecca A Hubbard, et al.
Breast Cancer Research and Treatment|March 24, 2010
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysisPatricia G Moorman, Edwin S Iversen, P Kelly Marcom, et al.
European Urology|October 29, 2021
Association of Inherited Mutations in DNA Repair Genes with Localized Prostate CancerDaniel J Lee, Ryan Hausler, Anh N Le, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in <i>BRCA1/2</i> CarriersGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Journal of General Internal Medicine|June 26, 2021
Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR StudyLydia E Pace, Nadine Tung, Yeonsoo S Lee, et al.
Pageof 37

Showing results (191-200 of 361) with videos related to

Sort By:
Pageof 37
Clinical Breast Cancer|February 14, 2008
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriersTara M Friebel, Susan M Domchek, Susan L Neuhausen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional AssayChunling Hu, Lisa R Susswein, Maegan E Roberts, et al.
Cell Reports|January 22, 2026
Immune gene diversity and STING1 variants in shaping cancer immunity across different genetic ancestry populationsXiaowen Hu, Jie Huang, Jiao Yuan, et al.
Cancer Research Communications|June 1, 2026
Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase 2a PLANETTE StudyRahul R Aggarwal, Antoine Italiano, Susan M Domchek, et al.
American Journal of Human Genetics|May 7, 2016
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast CancerKara N Maxwell, Steven N Hart, Joseph Vijai, et al.
Cancer|May 2, 2019
Detailed phenotyping reveals distinct trajectories of cardiovascular function and symptoms with exposure to modern breast cancer therapyBiniyam G Demissei, Brian S Finkelman, Rebecca A Hubbard, et al.
Breast Cancer Research and Treatment|March 24, 2010
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysisPatricia G Moorman, Edwin S Iversen, P Kelly Marcom, et al.
European Urology|October 29, 2021
Association of Inherited Mutations in DNA Repair Genes with Localized Prostate CancerDaniel J Lee, Ryan Hausler, Anh N Le, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in <i>BRCA1/2</i> CarriersGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Journal of General Internal Medicine|June 26, 2021
Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR StudyLydia E Pace, Nadine Tung, Yeonsoo S Lee, et al.
Pageof 37